The overall survival benefit in Chinese ALK(+) NSCLC patients received targeted therapies
接受靶向治疗的中国ALK(+)非小细胞肺癌患者的总体生存获益
期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-22-622
Tian, Guangming; Zhao, Xinliang; Nie, Jun; Dai, Ling; Hu, Weiheng; Zhang, Jie; Chen, Xiaoling; Han, Jindi; Ma, Xiangjuan; Wu, Di; Han, Sen; Long, Jieran; Wang, Yang; Zhang, Ziran; Fang, Jian